Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03584048 · ClinicalTrials.gov registry record
Charlotte Retention in Care Study
A clinical trial of HIV I Infection, sponsored by Epividian.
- Completed
- Registry status
- 6,500
- Enrollment target
- 4
- Study locations
NCT03584048: Completed study of HIV I Infection, sponsored by Epividian.
NCT03584048 is a study of HIV I Infection that has completed, run by Epividian. The registered enrollment target is 6,500 participants, above the 804-participant average among 5 other HIV I Infection trials with a reported enrollment target (708% higher). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03584048, a study of HIV I Infection, has completed, sponsored by Epividian.
- COMPLETED
- Registry status
- 6,500 participants
- Enrollment target
- 4
- Study locations
Study Summary
The objective of the Charlotte Retention in Care study is to assess if clinical decision support systems (CDSS) that produce standardized alerts for measures of retention in care across clinics in the city of Charlotte, North Carolina have the ability to increase retention in care measures within clinics and in surveillance reports.
Primary Outcome
Pre and post-baseline engagement level. Engagement level is defined as patients with 0, 1, or 2+ visits to physician (identified as a visit that included the collection of 1 viral load and/or 1 CD4 count lab test).
Conditions Studied
Interventions
- OTHER Alert to provider
Study Locations (4)
North Carolina
- Atrium Health - Charlotte
- Amity Group Foundation - Charlotte
- Ballantyne Family Medicine - Charlotte
- Rosedale Medical - Huntersville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,500 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2019-10-31 |
What the finished NCT03584048 record still lists
NCT03584048 is an observational study that tracks outcomes without assigning an intervention. Its 6,500 participants enrollment target places it among the larger protocols in the corpus, above the 804-participant average among 5 other HIV I Infection trials with a reported enrollment target (708% higher).
The record links to 1 condition, with HIV I Infection appearing as the primary indexed condition, and to 1 intervention - of which Alert to provider is the first listed.
NCT03584048 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03584048 about?
NCT03584048 is a clinical study titled "Charlotte Retention in Care Study". The objective of the Charlotte Retention in Care study is to assess if clinical decision support systems (CDSS) that produce standardized alerts for measures of retention in care across clinics in the city of Charlotte, North Carolina have the ability to increase retention in care measures within cl...
What is the current status of trial NCT03584048?
This trial is currently completed. The enrollment target is 6,500 participants. The study started on 2018-07-01. Estimated completion is 2019-10-31.
What conditions does trial NCT03584048 study?
This clinical trial studies the following conditions: HIV I Infection.
What interventions are being tested in trial NCT03584048?
The interventions under investigation include: Alert to provider (OTHER).
Who is sponsoring clinical trial NCT03584048?
This trial is sponsored by Epividian, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03584048 being conducted?
This trial has 4 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV I Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments
ACTIVE NOT RECRUITING · NA
-
To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV
COMPLETED · Phase 1
-
VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers
COMPLETED · Phase 1
-
Acute Effects of TCIG vs ECIG in PLWH
COMPLETED · NA
-
Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00505245 · 6,500 participants
New Assessment System in Measuring Symptom Distress in Cancer Patients
- NCT06821009 · 6,500 participants · NA
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
- NCT05369429 · 6,516 participants · NA
My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life
- NCT05143697 · 6,600 participants · NA
Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI